Foresite Capital Opportunity Management V »

Adicet Bio shares owned by Foresite Capital Opportunity Management V

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Foresite Capital Opportunity Management V from 13F filings

Historical chart of Foresite Capital Opportunity Management V investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by Foresite Capital Opportunity Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by Foresite Capital Opportunity Management V

Quarter filed Position value Share count Share price at filing
2022-09-30 $2.4M 170k 14.22
2022-06-30 $2.5M 170k 14.60
2022-03-31 $3.4M 170k 19.97
2021-12-31 $3.0M 170k 17.49

More positions owned by Foresite Capital Opportunity Management V

Pardes Biosciences
Theseus Pharmaceuticals
Gemini Therapeutics
Compass Therapeutics (CMPX)
Kinnate Biopharma
Adicet Bio (ACET)
Quantum-Si Incorporated Com Cl A (QSI)
Hims & Hers Health Com Cl A (HIMS)
Enanta Pharmaceuticals (ENTA)

View all positions for Foresite Capital Opportunity Management V

Top funds holding Adicet Bio

OrbiMed Advisors
Tang Capital Management
RA Capital Management
Goldman Sachs Group
Vanguard Group
Carlyle
Aquilo Capital Management
Millennium Management
Acadian Asset Management
Blackstone Group
Renaissance Technologies
D. E. Shaw & Co
Bridgeway Capital Management
Geode Capital Management
BlackRock

View all funds holding Adicet Bio